<DOC>
	<DOCNO>NCT01191099</DOCNO>
	<brief_summary>A single-center cohort study identify uni- multivariate association marker gene expression clinico-pathological parameter detection robust novel prognostic tool prostate cancer</brief_summary>
	<brief_title>Comprehensive Analysis Hypoxia Prostate Cancer : Diagnostic Markers Prognostic Significance</brief_title>
	<detailed_description>1 . To perform large scale assessment tissue hypoxia pimonidazole hypoxia marker gene expression human prostate cancer 2 . To characterize expression hypoxia/HIF-responsiveness myoglobin , cytoglobin , Î±-hemoglobin prostate tumor cell line 3 . To identify uni- multivariate association marker gene expression clinico-pathological parameter detection robust novel prognostic tool prostate cancer</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Inclusion criterion : Patients biopsyproven adenocarcinoma prostate treat radical prostatectomy Department Urology , University Hospital Zurich Written inform consent Exclusion criterion : Metastatic prostate cancer Contraindications class investigational product study , e.g . know hypersensitivity allergy investigational product Severe heart lung disease Severe liver kidney dysfunction Severe stridor Distant metastases Concurrent treatment malignant disease Prior hormonal therapy radiotherapy</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>